Lan Zheng

Title: Innovations by Lan Zheng in Anti-Tubercular Drug Formulation

Introduction

Lan Zheng is a notable inventor based in Fuyang, China. She has made significant contributions to the field of pharmaceuticals, particularly in the formulation of anti-tubercular drugs. Her innovative approach has led to advancements that enhance the stability and bioavailability of essential medications.

Latest Patents

Lan Zheng holds a patent for an oral solid formulation of a compound anti-tubercular drug. This patent, which includes the preparation method, focuses on a combination of active ingredients: rifampicin, isoniazid, pyrazinamide, and ethambutol hydrochloride. The formulation is designed as a coated tablet with a coated core or a coated three-layer tablet. Importantly, the two active ingredients, rifampicin and isoniazid, are formulated to avoid direct contact with each other. This innovative design not only improves the stability of the compound preparation but also enhances the bioavailability of rifampicin.

Career Highlights

Lan Zheng is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where she continues to work on groundbreaking pharmaceutical innovations. Her expertise in drug formulation has positioned her as a key player in the industry, contributing to the development of effective treatments for tuberculosis.

Collaborations

Lan Zheng collaborates with talented coworkers, including Qilan Zheng and Maojian Gu. Their combined efforts in research and development have fostered an environment of innovation and excellence in pharmaceutical sciences.

Conclusion

Lan Zheng's contributions to the field of anti-tubercular drug formulation exemplify the impact of innovative thinking in pharmaceuticals. Her work not only addresses critical health challenges but also sets a precedent for future advancements in drug development.